Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Precise and optimal delivery techniques of hemostatic powders in gastrointestinal bleeding

  • Hsueh-Chien Chiang (Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University) ;
  • Xi-Zhang Lin (Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University)
  • Received : 2025.06.28
  • Accepted : 2025.10.01
  • Published : 2026.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Gastrointestinal (GI) bleeding is associated with a high risk of mortality. While conventional endoscopic hemostasis methods, including epinephrine injection, heater probe coagulation, hemostatic clips, and band ligation, achieve an overall hemostasis rate of 85%-90%, 10%-20% of patients do not respond to these treatments. Several novel powders have shown promise as effective hemostatic agents. In this review, we discuss the evolution of endoscopic hemostasis and explore the potential of innovative hemostatic powder treatments in managing GI bleeding. Relevant articles were identified by searching PubMed from 2010 to 2025 using the keywords "hemostatic powder", "GI bleeding", and "endoscopic hemostasis". A review of recent PubMed articles on topical hemostatic powders used in endoscopy, including Hemospray, EndoClot, Ankaferd Blood Stopper, Nexpowder, and various drug-based powders, demonstrated that these agents offered high immediate hemostasis rates exceeding 90%. Topical hemostatic powders are valuable for managing active GI bleeding, especially when conventional endoscopic techniques are unsuccessful or technically challenging, such as refractory and tumor bleeding.

Keywords

References

  1. Jairath V, Hearnshaw S, Brunskill SJ, et al. Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev 2010;(9):CD006613.
  2. Lu MH, Chiang HC. Turn over the new leaf of the treatment in peptic ulcer bleeding: a review of the literature. Therap Adv Gastroenterol 2024;17:17562848241275318.
  3. Raphaeli T, Menon R. Current treatment of lower gastrointestinal hemorrhage. Clin Colon Rectal Surg 2012;25:219–227. https://doi.org/10.1055/s-00000049
  4. Laine L, Barkun AN, Saltzman JR, et al. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol 2021;116:899–917. https://doi.org/10.14309/ajg.0000000000001245
  5. Dave P, Romeu J, Messer J. Upper gastrointestinal bleeding in patients with portal hypertension: a reappraisal. J Clin Gastroenterol 1983;5:113–115. https://doi.org/10.1097/00004836-198304000-00004
  6. Adegboyega T, Rivadeneira D. Lower GI bleeding: an update on incidences and causes. Clin Colon Rectal Surg 2020;33:28–34. https://doi.org/10.1055/s-0039-1695035
  7. Tursi A, Scarpignato C, Strate LL, et al. Colonic diverticular disease. Nat Rev Dis Primers 2020;6:20. https://doi.org/10.1038/s41572-020-0153-5
  8. Sami SS, Al-Araji SA, Ragunath K. Review article: gastrointestinal angiodysplasia-pathogenesis, diagnosis and management. Aliment Pharmacol Ther 2014;39:15–34. https://doi.org/10.1111/apt.2013.39.issue-1
  9. Chatten K, Purssell H, Banerjee AK, et al. Glasgow Blatchford Score and risk stratifications in acute upper gastrointestinal bleed: can we extend this to 2 for urgent outpatient management? Clin Med (Lond) 2018;18:118–122. https://doi.org/10.7861/clinmedicine.18-2-118
  10. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012;107:345–360. https://doi.org/10.1038/ajg.2011.480
  11. Sreedharan A, Martin J, Leontiadis GI, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010;(7):CD005415.
  12. Hunt RH, Cederberg C, Dent J, et al. Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci 1995;40:24S–49S. https://doi.org/10.1007/BF02214870
  13. Sachs G, Shin JM, Howden CW. Review article: the clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 2006;23 Suppl 2:2–8. https://doi.org/10.1111/apt.2006.23.issue-s2
  14. Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000;118:S9–S31. https://doi.org/10.1016/S0016-5085(00)70004-7
  15. Ali Khan M, Howden CW. The role of proton pump inhibitors in the management of upper gastrointestinal disorders. Gastroenterol Hepatol (N Y) 2018;14:169–175.
  16. Hori Y, Imanishi A, Matsukawa J, et al. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases. J Pharmacol Exp Ther 2010;335:231–238. https://doi.org/10.1124/jpet.110.170274
  17. Andersson K, Carlsson E. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases. Pharmacol Ther 2005;108:294–307. https://doi.org/10.1016/j.pharmthera.2005.05.005
  18. Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label crossover study. Aliment Pharmacol Ther 2015;42:719–730. https://doi.org/10.1111/apt.2015.42.issue-6
  19. Abdel-Aziz Y, Metz DC, Howden CW. Review article: potassium-competitive acid blockers for the treatment of acid-related disorders. Aliment Pharmacol Ther 2021;53:794–809. https://doi.org/10.1111/apt.v53.7
  20. Geeratragool T, Kaosombatwattana U, Boonchote A, et al. Comparison of vonoprazan versus intravenous proton pump inhibitor for prevention of high-risk peptic ulcers rebleeding after successful endoscopic hemostasis: a multicenter randomized noninferiority trial. Gastroenterology 2024;167:778–787.
  21. Pattarapuntakul T, Wong T, Wetwittayakhlang P, et al. Efficacy of vonoprazan vs. intravenous proton pump inhibitor in prevention of re-bleeding of high-risk peptic ulcers: a randomized controlled pilot study. J Clin Med 2024;13:3606. https://doi.org/10.3390/jcm13123606
  22. Patel A, Laine L, Moayyedi P, et al. AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review. Gastroenterology 2024;167:1228–1238.
  23. Vergara M, Bennett C, Calvet X, et al. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers. Cochrane Database Syst Rev 2014;(10):CD005584.
  24. Kumar P, Fleischer DE. Thermal therapy for gastrointestinal bleeding. Gastrointest Endosc Clin N Am 1997;7:593–609. https://doi.org/10.1016/S1052-5157(18)30282-4
  25. Jang JY. Recent developments in the endoscopic treatment of patients with peptic ulcer bleeding. Clin Endosc 2016;49:417–420. https://doi.org/10.5946/ce.2016.135
  26. Tang RSY, Lau JYW. Monopolar hemostatic forceps with soft coagulation: earning a place in the endoscopic hemostasis repertoire for peptic ulcer bleeding. Gastrointest Endosc 2019;89:803–805. https://doi.org/10.1016/j.gie.2018.12.006
  27. Chau CH, Siu WT, Law BK, et al. Randomized controlled trial comparing epinephrine injection plus heat probe coagulation versus epinephrine injection plus argon plasma coagulation for bleeding peptic ulcers. Gastrointest Endosc 2003;57:455–461. https://doi.org/10.1016/S0016-5107(03)80008-1
  28. Zenker M. Argon plasma coagulation. GMS Krankenhhyg Interdiszip 2008;3:Doc15.
  29. Chauhan H, Mathews S, Rostami K. Argon plasma coagulation is not effective in every vascular lesion. Gastroenterol Hepatol Bed Bench 2016;9:232–236.
  30. Hepworth CC, Swain CP. Mechanical endoscopic methods of haemostasis for bleeding peptic ulcers: a review. Baillieres Best Pract Res Clin Gastroenterol 2000;14:467–476. https://doi.org/10.1053/bega.2000.0091
  31. Krishnan A, Velayutham V, Satyanesan J, et al. Role of endoscopic band ligation in management of non-variceal upper gastrointestinal bleeding. Trop Gastroenterol 2013;34:91–94. https://doi.org/10.7869/tg.2012.104
  32. Wang TJ, Aihara H, Thompson AC, et al. Choosing the right through-the-scope clip: a rigorous comparison of rotatability, whip, open/close precision, and closure strength (with videos). Gastrointest Endosc 2019;89:77–86. https://doi.org/10.1016/j.gie.2018.07.025
  33. Galloro G, Zullo A, Luglio G, et al. Endoscopic clipping in non-variceal upper gastrointestinal bleeding treatment. Clin Endosc 2022;55:339–346. https://doi.org/10.5946/ce.2021.249
  34. Wei MT, Ahn JY, Friedland S. Over-the-scope clip in the treatment of gastrointestinal leaks and perforations. Clin Endosc 2021;54:798–804. https://doi.org/10.5946/ce.2021.250
  35. Verlaan T, Voermans RP, van Berge Henegouwen MI, et al. Endoscopic closure of acute perforations of the GI tract: a systematic review of the literature. Gastrointest Endosc 2015;82:618–628. https://doi.org/10.1016/j.gie.2015.03.1977
  36. Schmidt A, Gölder S, Goetz M, et al. Over-the-scope clips are more effective than standard endoscopic therapy for patients with recurrent bleeding of peptic ulcers. Gastroenterology 2018;155:674–686. https://doi.org/10.1053/j.gastro.2018.05.037
  37. Barkun AN, Moosavi S, Martel M. Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleeding. Gastrointest Endosc 2013;77:692–700. https://doi.org/10.1016/j.gie.2013.01.020
  38. Changela K, Papafragkakis H, Ofori E, et al. Hemostatic powder spray: a new method for managing gastrointestinal bleeding. Therap Adv Gastroenterol 2015;8:125–135. https://doi.org/10.1177/1756283X15572587
  39. Jiang SX, Chahal D, Ali-Mohamad N, et al. Hemostatic powders for gastrointestinal bleeding: a review of old, new, and emerging agents in a rapidly advancing field. Endosc Int Open 2022;10:E1136–E1146. https://doi.org/10.1055/a-1836-8962
  40. Babiuc RD, Purcarea M, Sadagurschi R, et al. Use of Hemospray in the treatment of patients with acute UGIB: short review. J Med Life 2013;6:117–119.
  41. Sung JJ, Luo D, Wu JC, et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011;43:291–295. https://doi.org/10.1055/s-0030-1256311
  42. Bustamante-Balén M, Plumé G. Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding. World J Gastrointest Pathophysiol 2014;5:284–292. https://doi.org/10.4291/wjgp.v5.i3.284
  43. Haddara S, Jacques J, Lecleire S, et al. A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the "GRAPHE" registry). Endoscopy 2016;48:1084–1095. https://doi.org/10.1055/s-0042-116148
  44. Smith LA, Morris AJ, Stanley AJ. The use of hemospray in portal hypertensive bleeding; a case series. J Hepatol 2014;60:457–460. https://doi.org/10.1016/j.jhep.2013.10.008
  45. Ibrahim M, El-Mikkawy A, Mostafa I, et al. Endoscopic treatment of acute variceal hemorrhage by using hemostatic powder TC-325: a prospective pilot study. Gastrointest Endosc 2013;78:769–773. https://doi.org/10.1016/j.gie.2013.07.037
  46. Stanley AJ, Smith LA, Morris AJ. Use of hemostatic powder (Hemospray) in the management of refractory gastric variceal hemorrhage. Endoscopy 2013;45 Suppl 2 UCTN:E86–E87. https://doi.org/10.1055/s-00000012
  47. Holster IL, Brullet E, Kuipers EJ, et al. Hemospray treatment is effective for lower gastrointestinal bleeding. Endoscopy 2014;46:75–78.
  48. Chen YI, Barkun A, Nolan S. Hemostatic powder TC-325 in the management of upper and lower gastrointestinal bleeding: a twoyear experience at a single institution. Endoscopy 2015;47:167–171.
  49. Granata A, Curcio G, Barresi L, et al. Hemospray rescue treatment of severe refractory bleeding associated with ischemic colitis: a case series. Int J Colorectal Dis 2016;31:719–720. https://doi.org/10.1007/s00384-015-2212-z
  50. Hookey L, Barkun A, Sultanian R, et al. Successful hemostasis of active lower GI bleeding using a hemostatic powder as monotherapy, combination therapy, or rescue therapy. Gastrointest Endosc 2019;89:865–871. https://doi.org/10.1016/j.gie.2018.10.029
  51. Pittayanon R, Prueksapanich P, Rerknimitr R. The efficacy of Hemospray in patients with upper gastrointestinal bleeding from tumor. Endosc Int Open 2016;4:E933–E936. https://doi.org/10.1055/s-0042-109863
  52. Li XJ, Fung BM. Advancements in endoscopic hemostasis for non-variceal upper gastrointestinal bleeding. World J Gastrointest Endosc 2024;16:376–384.
  53. Baracat FI, de Moura DTH, Brunaldi VO, et al. Randomized controlled trial of hemostatic powder versus endoscopic clipping for non-variceal upper gastrointestinal bleeding. Surg Endosc 2020;34:317–324. https://doi.org/10.1007/s00464-019-06769-z
  54. Chen YI, Wyse J, Lu Y, et al. TC-325 hemostatic powder versus current standard of care in managing malignant GI bleeding: a pilot randomized clinical trial. Gastrointest Endosc 2020;91:321–328. https://doi.org/10.1016/j.gie.2019.08.005
  55. Pittayanon R, Khongka W, Linlawan S, et al. Hemostatic powder vs standard endoscopic treatment for gastrointestinal tumor bleeding: a multicenter randomized trial. Gastroenterology 2023;165:762–772. https://doi.org/10.1053/j.gastro.2023.05.042
  56. Kwek BEA, Ang TL, Ong PLJ, et al. TC-325 versus the conventional combined technique for endoscopic treatment of peptic ulcers with high-risk bleeding stigmata: A randomized pilot study. J Dig Dis 2017;18:323–329. https://doi.org/10.1111/cdd.2017.18.issue-6
  57. Mullady DK, Wang AY, Waschke KA. AGA clinical practice update on endoscopic therapies for non-variceal upper gastrointestinal bleeding: expert review. Gastroenterology 2020;159:1120–1128. https://doi.org/10.1053/j.gastro.2020.05.095
  58. Moosavi S, Chen YI, Barkun AN. TC-325 application leading to transient obstruction of a post-sphincterotomy biliary orifice. Endoscopy 2013;45 Suppl 2 UCTN:E130. https://doi.org/10.1055/s-00000012
  59. Yau AH, Ou G, Galorport C, et al. Safety and efficacy of Hemospray® in upper gastrointestinal bleeding. Can J Gastroenterol Hepatol 2014;28:72–76. https://doi.org/10.1155/2014/759436
  60. Papantoniou K, Kafentzi T, Sotiropoulos C, et al. Visceral perforation following hemostatic Powder TC-325 application in a patient with gastric cancer: a case report. Cureus 2025;17:e83611. https://doi.org/10.7759/cureus.83611
  61. Wang Y, Xu M, Dong H, et al. Effects of PerClot® on the healing of full-thickness skin wounds in rats. Acta Histochem 2012;114:311–317. https://doi.org/10.1016/j.acthis.2011.06.012
  62. Beg S, Al-Bakir I, Bhuva M, et al. Early clinical experience of the safety and efficacy of EndoClot in the management of non-variceal upper gastrointestinal bleeding. Endosc Int Open 2015;3:E605–E609. https://doi.org/10.1055/s-00025476
  63. Vitali F, Naegel A, Atreya R, et al. Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding. World J Gastroenterol 2019;25:1592–1602. https://doi.org/10.3748/wjg.v25.i13.1592
  64. Prei JC, Barmeyer C, Bürgel N, et al. EndoClot polysaccharide hemostatic system in nonvariceal gastrointestinal bleeding: results of a prospective multicenter observational pilot study. J Clin Gastroenterol 2016;50:e95–e100. https://doi.org/10.1097/MCG.0000000000000615
  65. Mourad FH, Leong RW. Role of hemostatic powders in the management of lower gastrointestinal bleeding: a review. J Gastroenterol Hepatol 2018;33:1445–1453.
  66. Kim YJ, Park JC, Kim EH, et al. Hemostatic powder application for control of acute upper gastrointestinal bleeding in patients with gastric malignancy. Endosc Int Open 2018;6:E700–E705. https://doi.org/10.1055/a-0593-5884
  67. Paoluzi OA, Cardamone C, Aucello A, et al. Efficacy of hemostatic powders as monotherapy or rescue therapy in gastrointestinal bleeding related to neoplastic or non-neoplastic lesions. Scand J Gastroenterol 2021;56:1506–1513. https://doi.org/10.1080/00365521.2021.1974088
  68. Beyazit Y, Kekilli M, Haznedaroglu IC, et al. Ankaferd hemostat in the management of gastrointestinal hemorrhages. World J Gastroenterol 2011;17:3962–3970. https://doi.org/10.3748/wjg.v17.i35.3962
  69. Karaman A, Baskol M, Gursoy S, et al. Endoscopic topical application of Ankaferd Blood Stopper® in gastrointestinal bleeding. J Altern Complement Med 2012;18:65–68. https://doi.org/10.1089/acm.2010.0827
  70. Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc 2010;71:873–875. https://doi.org/10.1016/j.gie.2009.08.021
  71. Beyazit Y, Akdogan M, Sayilir A, et al. Successful topical application of Ankaferd blood stopper in a patient with life-threatening fundal variceal bleeding despite cyanoacrilate injection. Clin Res Hepatol Gastroenterol 2012;36:e9–e11. https://doi.org/10.1016/j.clinre.2011.07.010
  72. Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis 2010;42:196–199. https://doi.org/10.1016/j.dld.2009.05.006
  73. Ozaslan E, Purnak T, Yildiz A, et al. The effect of Ankaferd blood stopper on severe radiation colitis. Endoscopy 2009;41 Suppl 2:E321–E322. https://doi.org/10.1055/s-0029-1215325
  74. Çiftçiler R, Koluman A, Haznedaroğlu İC, et al. Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance. Turk J Med Sci 2019;49:347–355. https://doi.org/10.3906/sag-1807-206
  75. Bang B, Lee E, Maeng J, et al. Efficacy of a novel endoscopically deliverable muco-adhesive hemostatic powder in an acute gastric bleeding porcine model. PLoS One 2019;14:e0216829. https://doi.org/10.1371/journal.pone.0216829
  76. Park JS, Bang BW, Hong SJ, et al. Efficacy of a novel hemostatic adhesive powder in patients with refractory upper gastrointestinal bleeding: a pilot study. Endoscopy 2019;51:458–462. https://doi.org/10.1055/a-0809-5276
  77. Park JS, Kim HK, Shin YW, et al. Novel hemostatic adhesive powder for nonvariceal upper gastrointestinal bleeding. Endosc Int Open 2019;7:E1763–E1767. https://doi.org/10.1055/a-0982-3194
  78. Shin J, Cha B, Park JS, et al. Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding. BMC Gastroenterol 2021;21:40. https://doi.org/10.1186/s12876-021-01611-0
  79. Cha B, Lee D, Shin J, et al. Hemostatic efficacy and safety of the hemostatic powder UI-EWD in patients with lower gastrointestinal bleeding. BMC Gastroenterol 2022;22:170. https://doi.org/10.1186/s12876-022-02247-4
  80. Seong G, Cha B, Shin J, et al. UI-EWD hemostatic powder in the management of refractory lower gastrointestinal bleeding: a multicenter study. Scand J Gastroenterol 2024;59:1172–1177. https://doi.org/10.1080/00365521.2024.2403120
  81. Picetti R, Shakur-Still H, Medcalf RL, et al. What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies. Blood Coagul Fibrinolysis 2019;30:1–10. https://doi.org/10.1097/MBC.0000000000000789
  82. Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia 2015;70 Suppl 1:50–53. https://doi.org/10.1111/anae.2014.70.issue-s1
  83. Farzanegan G, Ahmadpour F, Khoshmohabbat H, et al. The effect of topical tranexamic acid on intraoperative blood loss in patients undergoing posterior lumbar laminectomy and discectomy: a randomized, double-blind, controlled trial study. Asian Spine J 2022;16:857–864. https://doi.org/10.31616/asj.2021.0285
  84. Husain S, Ramos JA, Karaf JHA, et al. Efficacy of topical tranexamic acid to reduce bleeding in endoscopic sinus surgery for chronic rhinosinusitis with polyposis. Eur Arch Otorhinolaryngol 2023;280:737–741.
  85. Engelen ET, Schutgens RE, Mauser-Bunschoten EP, et al. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev 2018;7:CD012293. https://doi.org/10.1002/14651858
  86. Bennett C, Klingenberg SL, Langholz E, et al. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev 2014;2014:CD006640. https://doi.org/10.1002/14651858
  87. HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020;395:1927–1936. https://doi.org/10.1016/S0140-6736(20)30848-5
  88. Chiang HC, Chen PJ, Yang EH, et al. Precise application of topical tranexamic acid to enhance endoscopic hemostasis for peptic ulcer bleeding: a randomized controlled study (with video). Gastrointest Endosc 2023;98:755–764. https://doi.org/10.1016/j.gie.2023.06.013
  89. Yoshida N, Terao N, Nagashima R. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin. Arzneimittelforschung 1980;30:78–80.
  90. Nagashima R. Development and characteristics of sucralfate. J Clin Gastroenterol 1981;3:103–110.
  91. Nicaeus TE, Tolentino MJ, Adamis AP, et al. Sucralfate and basic fibroblast growth factor promote endothelial cell proliferation around porous alloplastic implants in vitro. Ophthalmic Plast Reconstr Surg 1996;12:235–239. https://doi.org/10.1097/00002341-199612000-00004
  92. Masuelli L, Tumino G, Turriziani M, et al. Topical use of sucralfate in epithelial wound healing: clinical evidences and molecular mechanisms of action. Recent Pat Inflamm Allergy Drug Discov 2010;4:25–36. https://doi.org/10.2174/187221310789895649
  93. Chiang HC, Chen PJ, Yang EH, et al. Clinical trial: precise administration of sucralfate powder in prevention of delayed postpolypectomy bleeding. a randomized controlled trial. Clin Transl Gastroenterol 2025;16:e00818. https://doi.org/10.14309/ctg.0000000000000818
  94. Saltzman JR. Hemostatic spray for the management of gastrointestinal bleeding. Gastroenterol Hepatol (N Y) 2019;15:40–43.
  95. Sugawara N, Iwatsubo T, Takeuchi T. Endoscopic hemostasis of an active hypopharyngeal hemorrhage via gel immersion endoscopy. Dig Endosc 2022;34:e141–e142. https://doi.org/10.1111/den.v34.6
  96. Subramaniam S, Kandiah K, Thayalasekaran S, et al. Haemostasis and prevention of bleeding related to ER: The role of a novel self-assembling peptide. United European Gastroenterol J 2019;7:155–162. https://doi.org/10.1177/2050640618811504
  97. de Nucci G, Reati R, Arena I, et al. Efficacy of a novel self-assembling peptide hemostatic gel as rescue therapy for refractory acute gastrointestinal bleeding. Endoscopy 2020;52:773–779. https://doi.org/10.1055/a-1145-3412
  98. Subramaniam S, Kandiah K, Chedgy F, et al. A novel self-assembling peptide for hemostasis during endoscopic submucosal dissection: a randomized controlled trial. Endoscopy 2021;53:27–35. https://doi.org/10.1055/a-1198-0558
  99. Dhindsa BS, Tun KM, Scholten KJ, et al. New alternative? self-assembling peptide in gastrointestinal bleeding: a systematic review and meta-analysis. Dig Dis Sci 2023;68:3694-6701. https://doi.org/10.1007/s10620-023-08009-w